Rivaroxaban axapharm 15 mg, Filmtabletten - 14 Swissmedic Key 69420004 Registration Holder axapharm ag Name Rivaroxaban axapharm 15 mg, Filmtabletten Date of registration 20.12.2024 Introduction of Sequence 20.12.2024 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 19.12.2029 Index Therapeuticus (BSV) Show package size 14 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680694200042 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 15 mg, cellulosum microcristallinum, lactosum monohydricum 21.58 mg, natrii laurilsulfas, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 3350, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.25 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 15 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactose Monohydrate 21.58 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 07.01.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
